Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line
ClinicalTrials.gov study NCT01430546. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of WVT078 in Patients With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT04123418. IPD Sharing: NO. Countries: 8. Publications: 1.
Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients
ClinicalTrials.gov study NCT01270932. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCE
ClinicalTrials.gov study NCT05552976. IPD Sharing: YES. Countries: 27. Publications: 0.
Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01042704. IPD Sharing: Not stated. Countries: 1. Publications: 22.
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
ClinicalTrials.gov study NCT00048958. IPD Sharing: Not stated. Countries: 1. Publications: 32.
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03933735. IPD Sharing: NO. Countries: 2. Publications: 1.
Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00028886. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04447573. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
ClinicalTrials.gov study NCT01575925. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent
ClinicalTrials.gov study NCT03768960. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem C
ClinicalTrials.gov study NCT02946333. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01371227. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02101944. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04835129. IPD Sharing: NO. Countries: 1. Publications: 1.
Two Schemes Response in Multiple Myeloma
ClinicalTrials.gov study NCT06284395. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01998971. IPD Sharing: Not stated. Countries: 3. Publications: 6.
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT04960579. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma
ClinicalTrials.gov study NCT02302495. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice
ClinicalTrials.gov study NCT02902900. IPD Sharing: Not stated. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.